NeuroblastomaPhase 2NCT02605421
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
Thiotepa, Cyclophosphamide, Melphalan, Etoposide
11 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Neuroblastoma and other childhood tumors11 studies
NeuroblastomaPhase 2NCT02605421
Thiotepa, Cyclophosphamide, Melphalan, Etoposide
Wilms TumorPhase 2NCT05985161
Selinexor
NeuroblastomaPhase 2NCT06057948
OPT-821 (QS-21), oral β-glucan
Anaplastic Kidney Wilms TumorPhase 2NCT04322318
Biopsy Procedure, Biospecimen Collection, Bone Scan, Carboplatin
Bilateral RetinoblastomaPhase 2NCT05504291
Biospecimen Collection, Carboplatin, Etoposide, Examination Under Anesthesia
NeuroblastomaPhase 2NCT07635056
CIML-NK Cells
Relapsed/Refractory Embryonal TumorsPhase 1NCT07172958
Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)
NeuroblastomaPhase 2NCT05489887
Naxitamab
Neuroblastoma RecurrentPhase 2NCT07085338
Temozolomide, Irinotecan, hu14.18K322A, N803
NeuroblastomaPhase 2NCT06450041
Universal Donor (UD) TGFβi NK Cells, Temozolomide, Irinotecan, Dinutuximab
NeuroblastomaPhase 1NCT03294954Papers
GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children With Neuroblastoma